All three MutL complexes are required for repeat expansion in a human stem cell model of CAG-repeat expansion mediated glutaminase deficiency.

GDPAG GLSD Glutaminase deficiency disorder Microsatellite instability Mismatch repair (MMR) Repeat expansion disease

Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
14 Jun 2024
Historique:
received: 09 01 2024
accepted: 10 06 2024
medline: 15 6 2024
pubmed: 15 6 2024
entrez: 14 6 2024
Statut: epublish

Résumé

The Repeat Expansion Diseases (REDs) arise from the expansion of a disease-specific short tandem repeat (STR). Different REDs differ with respect to the repeat involved, the cells that are most expansion prone and the extent of expansion. Furthermore, whether these diseases share a common expansion mechanism is unclear. To date, expansion has only been studied in a limited number of REDs. Here we report the first studies of the expansion mechanism in induced pluripotent stem cells derived from a patient with a form of the glutaminase deficiency disorder known as Global Developmental Delay, Progressive Ataxia, And Elevated Glutamine (GDPAG; OMIM# 618412) caused by the expansion of a CAG-STR in the 5' UTR of the glutaminase (GLS) gene. We show that alleles with as few as ~ 120 repeats show detectable expansions in culture despite relatively low levels of R-loops formed at this locus. Additionally, using a CRISPR-Cas9 knockout approach we show that PMS2 and MLH3, the constituents of MutLα and MutLγ, the 2 mammalian MutL complexes known to be involved in mismatch repair (MMR), are essential for expansion. Furthermore, PMS1, a component of a less well understood MutL complex, MutLβ, is also important, if not essential, for repeat expansion in these cells. Our results provide insights into the factors important for expansion and lend weight to the idea that, despite some differences, the same mechanism is responsible for expansion in many, if not all, REDs.

Identifiants

pubmed: 38877099
doi: 10.1038/s41598-024-64480-z
pii: 10.1038/s41598-024-64480-z
doi:

Substances chimiques

Glutaminase EC 3.5.1.2
MutL Proteins EC 3.6.1.3

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

13772

Subventions

Organisme : NIDDK NIH HHS
ID : DK057808
Pays : United States

Informations de copyright

© 2024. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.

Références

van Kuilenburg, A. B. P. et al. Glutaminase deficiency caused by short tandem repeat expansion in GLS. N. Engl. J. Med. 380, 1433–1441. https://doi.org/10.1056/NEJMoa1806627 (2019).
doi: 10.1056/NEJMoa1806627 pubmed: 30970188 pmcid: 8819703
Paulson, H. Repeat expansion diseases. Handb. Clin. Neurol. 147, 105–123. https://doi.org/10.1016/B978-0-444-63233-3.00009-9 (2018).
doi: 10.1016/B978-0-444-63233-3.00009-9 pubmed: 29325606 pmcid: 6485936
Zhao, X. & Usdin, K. (Dys)function follows form: nucleic acid structure, repeat expansion, and disease pathology in FMR1 disorders. Int. J. Mol. Sci. https://doi.org/10.3390/ijms22179167 (2021).
doi: 10.3390/ijms22179167 pubmed: 35008842 pmcid: 8745693
Zhao, X. et al. Repeat instability in the fragile X-related disorders: Lessons from a mouse model. Brain Sci. https://doi.org/10.3390/brainsci9030052 (2019).
doi: 10.3390/brainsci9030052 pubmed: 31319495 pmcid: 6681410
Wheeler, V. C. & Dion, V. Modifiers of CAG/CTG repeat instability: Insights from Mammalian models. J. Huntingt. Dis. 10, 123–148. https://doi.org/10.3233/JHD-200426 (2021).
doi: 10.3233/JHD-200426
McAllister, B. et al. Exome sequencing of individuals with Huntington’s disease implicates FAN1 nuclease activity in slowing CAG expansion and disease onset. Nat. Neurosci. 25, 446–457. https://doi.org/10.1038/s41593-022-01033-5 (2022).
doi: 10.1038/s41593-022-01033-5 pubmed: 35379994 pmcid: 8986535
Kim, K. H. et al. Genetic and functional analyses point to FAN1 as the source of multiple Huntington disease modifier effects. Am. J. Hum. Genet. 107, 96–110. https://doi.org/10.1016/j.ajhg.2020.05.012 (2020).
doi: 10.1016/j.ajhg.2020.05.012 pubmed: 32589923 pmcid: 7332667
Hwang, Y. H. et al. Both cis and trans-acting genetic factors drive somatic instability in female carriers of the FMR1 premutation. Sci. Rep. 12, 10419. https://doi.org/10.1038/s41598-022-14183-0 (2022).
doi: 10.1038/s41598-022-14183-0 pubmed: 35729184 pmcid: 9213438
Flower, M. et al. MSH3 modifies somatic instability and disease severity in Huntington’s and myotonic dystrophy type 1. Brain 142, 1876–1886. https://doi.org/10.1093/brain/awz115 (2019).
doi: 10.1093/brain/awz115 pubmed: 31216018 pmcid: 6598626
Lin, Y., Leng, M., Wan, M. & Wilson, J. H. Convergent transcription through a long CAG tract destabilizes repeats and induces apoptosis. Mol. Cell. Biol. 30, 4435–4451. https://doi.org/10.1128/MCB.00332-10 (2010).
doi: 10.1128/MCB.00332-10 pubmed: 20647539 pmcid: 2937530
Miller, C. J., Kim, G. Y., Zhao, X. & Usdin, K. All three mammalian MutL complexes are required for repeat expansion in a mouse cell model of the Fragile X-related disorders. PLoS Genet. 16, e1008902. https://doi.org/10.1371/journal.pgen.1008902 (2020).
doi: 10.1371/journal.pgen.1008902 pubmed: 32589669 pmcid: 7347238
Gomes-Pereira, M., Fortune, M. T., Ingram, L., McAbney, J. P. & Monckton, D. G. Pms2 is a genetic enhancer of trinucleotide CAG.CTG repeat somatic mosaicism: Implications for the mechanism of triplet repeat expansion. Hum. Mol. Genet. 13, 1815–1825. https://doi.org/10.1093/hmg/ddh186 (2004).
doi: 10.1093/hmg/ddh186 pubmed: 15198993
Bourn, R. L. et al. Pms2 suppresses large expansions of the (GAA.TTC)n sequence in neuronal tissues. PLoS One 7, e47085. https://doi.org/10.1371/journal.pone.0047085 (2012).
doi: 10.1371/journal.pone.0047085 pubmed: 23071719 pmcid: 3469490
Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281–2308. https://doi.org/10.1038/nprot.2013.143 (2013).
doi: 10.1038/nprot.2013.143 pubmed: 24157548 pmcid: 3969860
Singer, M. et al. A Distinct gene module for dysfunction uncoupled from activation in tumor-infiltrating T cells. Cell 166, 1500–1511 e1509 (2016). https://doi.org/10.1016/j.cell.2016.08.052
Okita, K. et al. An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells. Stem Cells 31, 458–466. https://doi.org/10.1002/stem.1293 (2013).
doi: 10.1002/stem.1293 pubmed: 23193063
Gibson, D. G. et al. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat. Methods 6, 343–345. https://doi.org/10.1038/nmeth.1318 (2009).
doi: 10.1038/nmeth.1318 pubmed: 19363495
Clendenning, M. et al. Long-range PCR facilitates the identification of PMS2-specific mutations. Hum. Mutat. 27, 490–495. https://doi.org/10.1002/humu.20318 (2006).
doi: 10.1002/humu.20318 pubmed: 16619239
Concordet, J. P. & Haeussler, M. CRISPOR: Intuitive guide selection for CRISPR/Cas9 genome editing experiments and screens. Nucleic Acids Res. 46, W242–W245. https://doi.org/10.1093/nar/gky354 (2018).
doi: 10.1093/nar/gky354 pubmed: 29762716 pmcid: 6030908
Beers, J. et al. A cost-effective and efficient reprogramming platform for large-scale production of integration-free human induced pluripotent stem cells in chemically defined culture. Sci. Rep. 5, 11319. https://doi.org/10.1038/srep11319 (2015).
doi: 10.1038/srep11319 pubmed: 26066579 pmcid: 4464084
Miller, S. A., Dykes, D. D. & Polesky, H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16, 1215. https://doi.org/10.1093/nar/16.3.1215 (1988).
doi: 10.1093/nar/16.3.1215 pubmed: 3344216 pmcid: 334765
Yao, X. et al. Different mutator phenotypes in Mlh1- versus Pms2-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 96, 6850–6855. https://doi.org/10.1073/pnas.96.12.6850 (1999).
doi: 10.1073/pnas.96.12.6850 pubmed: 10359802 pmcid: 22005
Boland, C. R., Koi, M., Chang, D. K. & Carethers, J. M. The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: From bench to bedside. Fam. Cancer 7, 41–52. https://doi.org/10.1007/s10689-007-9145-9 (2008).
doi: 10.1007/s10689-007-9145-9 pubmed: 17636426
Hayward, B. E. & Usdin, K. Assays for determining repeat number, methylation status, and AGG interruptions in the fragile X-related disorders. Methods Mol. Biol. 1942, 49–59. https://doi.org/10.1007/978-1-4939-9080-1_4 (2019).
doi: 10.1007/978-1-4939-9080-1_4 pubmed: 30900174 pmcid: 9435319
Hayward, B. E., Zhou, Y., Kumari, D. & Usdin, K. A set of assays for the comprehensive analysis of FMR1 Alleles in the Fragile X-related disorders. J. Mol. Diagn. 18, 762–774. https://doi.org/10.1016/j.jmoldx.2016.06.001 (2016).
doi: 10.1016/j.jmoldx.2016.06.001 pubmed: 27528259 pmcid: 5807930
Goold, R. et al. FAN1 controls mismatch repair complex assembly via MLH1 retention to stabilize CAG repeat expansion in Huntington’s disease. Cell Rep. 36, 109649. https://doi.org/10.1016/j.celrep.2021.109649 (2021).
doi: 10.1016/j.celrep.2021.109649 pubmed: 34469738 pmcid: 8424649
Du, J., Campau, E., Soragni, E., Jespersen, C. & Gottesfeld, J. M. Length-dependent CTG.CAG triplet-repeat expansion in myotonic dystrophy patient-derived induced pluripotent stem cells. Hum. Mol. Genet. 22, 5276–5287. https://doi.org/10.1093/hmg/ddt386 (2013).
doi: 10.1093/hmg/ddt386 pubmed: 23933738 pmcid: 3842182
Ku, S. et al. Friedreich’s ataxia induced pluripotent stem cells model intergenerational GAA⋅TTC triplet repeat instability. Cell Stem Cell 7, 631–637. https://doi.org/10.1016/j.stem.2010.09.014 (2010).
doi: 10.1016/j.stem.2010.09.014 pubmed: 21040903 pmcid: 2987635
Møllersen, L., Rowe, A. D., Larsen, E., Rognes, T. & Klungland, A. Continuous and periodic expansion of CAG repeats in Huntington’s disease R6/1 mice. PLoS Genet. 6, e1001242. https://doi.org/10.1371/journal.pgen.1001242 (2010).
doi: 10.1371/journal.pgen.1001242 pubmed: 21170307 pmcid: 3000365
Su, X. A. & Freudenreich, C. H. Cytosine deamination and base excision repair cause R-loop-induced CAG repeat fragility and instability in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. U. S. A. 114, E8392–E8401. https://doi.org/10.1073/pnas.1711283114 (2017).
doi: 10.1073/pnas.1711283114 pubmed: 28923949 pmcid: 5635916
Neil, A. J., Liang, M. U., Khristich, A. N., Shah, K. A. & Mirkin, S. M. RNA-DNA hybrids promote the expansion of Friedreich’s ataxia (GAA)n repeats via break-induced replication. Nucleic Acids Res. 46, 3487–3497. https://doi.org/10.1093/nar/gky099 (2018).
doi: 10.1093/nar/gky099 pubmed: 29447396 pmcid: 5909440
Khristich, A. N. & Mirkin, S. M. On the wrong DNA track: Molecular mechanisms of repeat-mediated genome instability. J. Biol. Chem. 295, 4134–4170. https://doi.org/10.1074/jbc.REV119.007678 (2020).
doi: 10.1074/jbc.REV119.007678 pubmed: 32060097 pmcid: 7105313
McIvor, E. I., Polak, U. & Napierala, M. New insights into repeat instability: Role of RNA*DNA hybrids. RNA Biol. 7, 551–558. https://doi.org/10.4161/rna.7.5.12745 (2010).
doi: 10.4161/rna.7.5.12745 pubmed: 20729633 pmcid: 3073251
Boguslawski, S. J. et al. Characterization of monoclonal antibody to DNA.RNA and its application to immunodetection of hybrids. J. Immunol. Methods 89, 123–130. https://doi.org/10.1016/0022-1759(86)90040-2 (1986).
doi: 10.1016/0022-1759(86)90040-2 pubmed: 2422282
Li, L., Matsui, M. & Corey, D. R. Activating frataxin expression by repeat-targeted nucleic acids. Nat. Commun. 7, 10606. https://doi.org/10.1038/ncomms10606 (2016).
doi: 10.1038/ncomms10606 pubmed: 26842135 pmcid: 4742999
Loomis, E. W., Sanz, L. A., Chedin, F. & Hagerman, P. J. Transcription-associated R-loop formation across the human FMR1 CGG-repeat region. PLoS Genet. 10, e1004294. https://doi.org/10.1371/journal.pgen.1004294 (2014).
doi: 10.1371/journal.pgen.1004294 pubmed: 24743386 pmcid: 3990486
Kumari, D. & Usdin, K. Sustained expression of FMR1 mRNA from reactivated fragile X syndrome alleles after treatment with small molecules that prevent trimethylation of H3K27. Hum. Mol. Genet. 25, 3689–3698. https://doi.org/10.1093/hmg/ddw215 (2016).
doi: 10.1093/hmg/ddw215 pubmed: 27378697 pmcid: 5216614
Abu Diab, M. et al. The G-rich Repeats in FMR1 and C9orf72 Loci Are Hotspots for Local Unpairing of DNA. Genetics 210, 1239–1252. https://doi.org/10.1534/genetics.118.301672 (2018).
doi: 10.1534/genetics.118.301672 pubmed: 30396881 pmcid: 6283162
Thongthip, S., Carlson, A., Crossley, M. P. & Schwer, B. Relationships between genome-wide R-loop distribution and classes of recurrent DNA breaks in neural stem/progenitor cells. Sci. Rep. 12, 13373. https://doi.org/10.1038/s41598-022-17452-0 (2022).
doi: 10.1038/s41598-022-17452-0 pubmed: 35927309 pmcid: 9352722
Ginno, P. A., Lott, P. L., Christensen, H. C., Korf, I. & Chedin, F. R-loop formation is a distinctive characteristic of unmethylated human CpG island promoters. Mol. Cell 45, 814–825. https://doi.org/10.1016/j.molcel.2012.01.017 (2012).
doi: 10.1016/j.molcel.2012.01.017 pubmed: 22387027 pmcid: 3319272
Kadyrova, L. Y., Gujar, V., Burdett, V., Modrich, P. L. & Kadyrov, F. A. Human MutLgamma, the MLH1-MLH3 heterodimer, is an endonuclease that promotes DNA expansion. Proc. Natl. Acad. Sci. U. S. A. 117, 3535–3542. https://doi.org/10.1073/pnas.1914718117 (2020).
doi: 10.1073/pnas.1914718117 pubmed: 32015124 pmcid: 7035508
Pluciennik, A. et al. PCNA function in the activation and strand direction of MutLalpha endonuclease in mismatch repair. Proc. Natl. Acad. Sci. U. S. A. 107, 16066–16071. https://doi.org/10.1073/pnas.1010662107 (2010).
doi: 10.1073/pnas.1010662107 pubmed: 20713735 pmcid: 2941292
Prolla, T. A. et al. Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair. Nat. Genet. 18, 276–279. https://doi.org/10.1038/ng0398-276 (1998).
doi: 10.1038/ng0398-276 pubmed: 9500552
Iyer, R. R. & Pluciennik, A. DNA mismatch repair and its role in Huntington’s disease. J. Huntingt. Dis. 10, 75–94. https://doi.org/10.3233/JHD-200438 (2021).
doi: 10.3233/JHD-200438

Auteurs

Bruce Hayward (B)

Section On Gene Structure and Disease, Laboratory of Cell and Molecular Biology, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.

Daman Kumari (D)

Section On Gene Structure and Disease, Laboratory of Cell and Molecular Biology, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.

Saikat Santra (S)

Birmingham Women's and Children's NHS Foundation Trust, Birmingham, B15 2TG, UK.

Clara D M van Karnebeek (CDM)

Emma Center for Personalized Medicine, Departments of Pediatrics and Human Genetics, Amsterdam Gastro-Enterology Endocrinology and Metabolism, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
United for Metabolic Diseases, Amsterdam, The Netherlands.

André B P van Kuilenburg (ABP)

Laboratory Genetic Metabolic Diseases, Department of Clinical Chemistry, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, The Netherlands.

Karen Usdin (K)

Section On Gene Structure and Disease, Laboratory of Cell and Molecular Biology, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, 20892, USA. karenu@nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH